IBRX

Immunitybio Inc

• Seeking Alpha·12h ago

  BUZZ Investing: Markets Look Through Intra-Period Volatility

• Simply Wall St·3d ago

  ImmunityBio (IBRX) Shares Moved, What Is Behind The Fresh Attention?

• Simply Wall St·6d ago

  Does Adding Jim Yong Kim to Leadership Shift ImmunityBio’s Global Strategy Narrative (IBRX)?

• TipRanks·08/10 13:40

  Unusually active option classes on open August 10th

• TipRanks·08/10 13:10

  ImmunityBio appoints Kim as Vice Chairman

• Dow Jones·08/10 13:02

  *ImmunityBio: Kim Will Serve in a Newly Created Office of the Executive Chmn >IBRX

• Simply Wall St·08/09 17:29

  ImmunityBio (IBRX) Tests Its Valuation After UAE ANKTIVA Approval Expands Its Reach

• Simply Wall St·08/08 08:29

  Why ImmunityBio (IBRX) Is Up 6.6% After ANKTIVA’s UAE Expansion and Mixed Q2 Results – And What's Next

• Simply Wall St·08/06 21:27

  ImmunityBio (IBRX) Stock May Trade At A Premium To Fair Value

• Simply Wall St·08/05 11:05

  Insiders Favor Dave And 2 More High Growth Companies

• TipRanks·08/05 10:25

  BTIG’s Mukherjee Reiterates Buy on ImmunityBio as ANKTIVA Growth, Upcoming QUILT-2.005 Milestones Support Unchanged $12 Price Target

• TipRanks·08/04 18:05

  ImmunityBio: ANKTIVA’s Sustained Growth and Regulatory Catalysts Support Reaffirmed Buy Rating and Unchanged $15 Price Target

• NASDAQ·08/04 12:50

  ImmunityBio (IBRX) Reports Q2 Loss, Beats Revenue Estimates

• Dow Jones·08/04 11:31

  *ImmunityBio 2Q Rev $51.2M >IBRX

• Dow Jones·08/04 11:31

  *ImmunityBio 2Q Loss/Shr 22c >IBRX